{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:50:10Z","timestamp":1782888610641,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"National Institutes of Health Institute of Clinical and Translational Sciences","award":["UL1 TR002345"],"award-info":[{"award-number":["UL1 TR002345"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.antiviral.2018.06.010","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T01:28:17Z","timestamp":1529026097000},"page":"102-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Antifungal drug ciclopirox olamine reduces HSV-1 replication and disease in mice"],"prefix":"10.1016","volume":"156","author":[{"given":"Kaelin M.","family":"Bernier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda A.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.antiviral.2018.06.010_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0738-081X(91)90075-V","article-title":"Ciclopirox olamine: a hydroxypyridone antifungal agent","volume":"9","author":"Abrams","year":"1991","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.antiviral.2018.06.010_bib2","first-page":"151","article-title":"Monitoring drug resistance for herpesviruses","volume":"24","author":"Andrei","year":"2000","journal-title":"Meth. Mol. Med."},{"issue":"8","key":"10.1016\/j.antiviral.2018.06.010_bib3","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/infdis\/jit019","article-title":"Heterogeneity and evolution of thymidine kinase and DNA polymerase mutants of herpes simplex virus type 1: implications for antiviral therapy","volume":"207","author":"Andrei","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.06.010_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/OPTH.S80475","article-title":"Herpes simplex keratitis: challenges in diagnosis and clinical management","volume":"11","author":"Azher","year":"2017","journal-title":"Clin. Ophthalmol."},{"issue":"4 Suppl. l","key":"10.1016\/j.antiviral.2018.06.010_bib5","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1067\/mjd.2000.109072","article-title":"Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis","volume":"43","author":"Bohn","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.antiviral.2018.06.010_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1099\/0022-1317-18-3-329","article-title":"Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map","volume":"18","author":"Brown","year":"1973","journal-title":"J. Gen. Virol."},{"issue":"12","key":"10.1016\/j.antiviral.2018.06.010_bib7","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.1128\/JVI.00374-12","article-title":"Identification of a divalent metal cation binding site in herpes simplex virus 1 (HSV-1) ICP8 required for HSV replication","volume":"86","author":"Bryant","year":"2012","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2018.06.010_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcv.2013.05.001","article-title":"Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis","volume":"58","author":"Burrel","year":"2013","journal-title":"J. Clin. Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2018.06.010_bib9","first-page":"670","article-title":"HOE 296, a new antimycotic compound with a broad antimicrobial spectrum. Laboratory results","volume":"23","author":"Dittmar","year":"1973","journal-title":"Arzneimittelforschung"},{"issue":"1","key":"10.1016\/j.antiviral.2018.06.010_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1128\/iai.40.1.103-112.1983","article-title":"Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB\/c mice","volume":"40","author":"Dix","year":"1983","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.antiviral.2018.06.010_bib11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1086\/590668","article-title":"Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis","volume":"198","author":"Duan","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.antiviral.2018.06.010_bib12","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1086\/606028","article-title":"Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis","volume":"200","author":"Duan","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"14","key":"10.1016\/j.antiviral.2018.06.010_bib13","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2009-03-209965","article-title":"Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells","volume":"114","author":"Eberhard","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.antiviral.2018.06.010_bib14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.survophthal.2012.01.005","article-title":"Herpes simplex epithelial and stromal keratitis: an epidemiologic update","volume":"57","author":"Farooq","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.antiviral.2018.06.010_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/bmb\/ldt011","article-title":"Recent developments in anti-herpesvirus drugs","volume":"106","author":"Field","year":"2013","journal-title":"Br. Med. Bull."},{"issue":"2","key":"10.1016\/j.antiviral.2018.06.010_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1368-7646(02)00021-3","article-title":"Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms","volume":"5","author":"Gilbert","year":"2002","journal-title":"Drug Resist. Updates"},{"issue":"9","key":"10.1016\/j.antiviral.2018.06.010_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074414","article-title":"Drug-induced reactivation of apoptosis abrogates HIV-1 infection","volume":"8","author":"Hanauske-Abel","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2018.06.010_bib18","first-page":"91","article-title":"Therapy of seborrheic eczema with an antifungal agent with an antiphlogistic effect","volume":"34","author":"Hanel","year":"1991","journal-title":"Mycoses"},{"key":"10.1016\/j.antiviral.2018.06.010_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1742-4690-6-90","article-title":"Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A","volume":"6","author":"Hoque","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.antiviral.2018.06.010_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.coviro.2014.06.003","article-title":"Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance","volume":"8","author":"James","year":"2014","journal-title":"Curr Opin Virol"},{"issue":"9816","key":"10.1016\/j.antiviral.2018.06.010_bib21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(11)61750-9","article-title":"Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials","volume":"379","author":"Johnston","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.antiviral.2018.06.010_bib22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2165\/00003495-198529040-00002","article-title":"Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use","volume":"29","author":"Jue","year":"1985","journal-title":"Drugs"},{"issue":"1 Pt 2","key":"10.1016\/j.antiviral.2018.06.010_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0190-9622(88)70022-5","article-title":"History, pharmacokinetics, and pharmacology of acyclovir","volume":"18","author":"King","year":"1988","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.antiviral.2018.06.010_bib24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/jvi.43.1.314-324.1982","article-title":"Definition of a series of stages in the association of two herpesviral proteins with the cell nucleus","volume":"43","author":"Knipe","year":"1982","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2018.06.010_bib25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1001\/archopht.121.1.108","article-title":"Prevention of herpes simplex virus eye disease: a cost-effectiveness analysis","volume":"121","author":"Lairson","year":"2003","journal-title":"Arch. Ophthalmol."},{"issue":"4","key":"10.1016\/j.antiviral.2018.06.010_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00403-006-0679-8","article-title":"Anti-inflammatory and anti-itch activity of sertaconazole nitrate","volume":"298","author":"Liebel","year":"2006","journal-title":"Arch. Dermatol. Res."},{"issue":"2","key":"10.1016\/j.antiviral.2018.06.010_bib27","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.virol.2005.12.016","article-title":"Transgenic reporter mouse for bioluminescence imaging of herpes simplex virus 1 infection in living mice","volume":"347","author":"Luker","year":"2006","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.antiviral.2018.06.010_bib28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/jvi.68.2.689-696.1994","article-title":"Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection","volume":"68","author":"Morrison","year":"1994","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2018.06.010_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/embor.2008.256","article-title":"Retroviral integrase superfamily: the structural perspective","volume":"10","author":"Nowotny","year":"2009","journal-title":"EMBO Rep."},{"issue":"3","key":"10.1016\/j.antiviral.2018.06.010_bib30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.sbi.2009.04.006","article-title":"Structural and functional modules in RNA interference","volume":"19","author":"Nowotny","year":"2009","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"2","key":"10.1016\/j.antiviral.2018.06.010_bib31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/AAC.00615-10","article-title":"Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management","volume":"55","author":"Piret","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.antiviral.2018.06.010_bib32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1086\/314900","article-title":"Characterization of the DNA polymerase and thymidine kinase genes of herpes simplex virus isolates from AIDS patients in whom acyclovir and foscarnet therapy sequentially failed","volume":"180","author":"Schmit","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.antiviral.2018.06.010_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002862","article-title":"The HSV-1 exonuclease, UL12, stimulates recombination by a single strand annealing mechanism","volume":"8","author":"Schumacher","year":"2012","journal-title":"PLoS Pathog."},{"issue":"12","key":"10.1016\/j.antiviral.2018.06.010_bib34","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1128\/JVI.00311-13","article-title":"The structure of the herpes simplex virus DNA-packaging terminase pUL15 nuclease domain suggests an evolutionary lineage among eukaryotic and prokaryotic viruses","volume":"87","author":"Selvarajan","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.06.010_bib35","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3181\/00379727-115-29045","article-title":"Relationship between the envelope and the infectivity of herpes simplex virus","volume":"115","author":"Smith","year":"1964","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"16","key":"10.1016\/j.antiviral.2018.06.010_bib36","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.2165\/11538110-000000000-00000","article-title":"Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent","volume":"70","author":"Subissi","year":"2010","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.antiviral.2018.06.010_bib37","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1128\/JVI.75.11.5069-5075.2001","article-title":"Herpes simplex virus type 1 corneal infection results in periocular disease by zosteriform spread","volume":"75","author":"Summers","year":"2001","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.antiviral.2018.06.010_bib38","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1128\/AAC.03875-14","article-title":"Inhibitors of nucleotidyltransferase superfamily enzymes suppress herpes simplex virus replication","volume":"58","author":"Tavis","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.antiviral.2018.06.010_bib39","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/infdis\/jit350","article-title":"Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis","volume":"208","author":"van Velzen","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.06.010_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-405880-4.00001-9","article-title":"Antiviral agents for herpes simplex virus","volume":"67","author":"Vere Hodge","year":"2013","journal-title":"Adv. Pharmacol."},{"issue":"2","key":"10.1016\/j.antiviral.2018.06.010_bib41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jcv.2011.06.009","article-title":"Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children","volume":"52","author":"Wang","year":"2011","journal-title":"J. Clin. Virol."},{"issue":"9","key":"10.1016\/j.antiviral.2018.06.010_bib42","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a013011","article-title":"Herpes simplex viruses: mechanisms of DNA replication","volume":"4","author":"Weller","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.antiviral.2018.06.010_bib43","series-title":"Fields Virology","first-page":"2461","article-title":"Herpes simplex viruses","volume":"vol. 2","author":"Whitley","year":"2001"},{"issue":"Suppl. l","key":"10.1016\/j.antiviral.2018.06.010_bib44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/02713689109020374","article-title":"Ocular acyclovir delivery by collagen discs: a mouse model to screen anti-viral agents","volume":"10","author":"Willey","year":"1991","journal-title":"Curr. Eye Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:26:54Z","timestamp":1759062414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218303164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":44,"alternative-id":["S0166354218303164"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.06.010","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal drug ciclopirox olamine reduces HSV-1 replication and disease in mice","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}